Ramesh Kumar, President and CEO at Onconova Therapeutics, Inc. (ONTX), sold 33,543 shares at $15.11 ($506K) on 2014-02-10, disclosed to the SEC on 2014-02-11.
Scheduled sale ($506k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.02 | 13,543 | $203K | 40.2% |
| 2 | $15.11 | 20,000 | $302K | 59.8% |
| Total | $15.07 avg | 33,543 | $506K | 100% |
| Filing → |
| OCGN | SELL | 2022-04-20 | $21K | — | Filing → |
| OCGN | SELL | 2022-01-20 | $31K | — | Filing → |
| OCGN | SELL | 2021-10-20 | $122K | — | Filing → |